Global M&A Investment Checklist: 10 Things Sophisticated Investors Should Assess Before Allocating

1. Is the investment thesis clear and specific?

A strong M&A opportunity should start with a clear strategic case. What is being acquired, why does it matter, and where is value expected to come from?

That may sound obvious, but weak deals often begin with broad ambition and vague rationale. Stronger deals are built on a defined thesis, whether that is consolidation, operational improvement, geographic expansion, product capability, customer access, or capital efficiency. PwC’s work on value creation in M&A makes the point that deal activity should stay aligned to a clear long-term strategic vision rather than opportunistic activity alone. McKinsey makes a similar point in its 2025 CEO briefing, arguing that winning acquirers work from a well-defined M&A blueprint aligned with strategic goals.

If the reason for the deal cannot be explained simply and commercially, that is usually an early warning sign.

2. What are the actual value creation drivers?

The deal itself is not the return driver. Execution is. Experienced investors usually want to know where value is expected to come from after completion. That may include cost synergies, capital efficiencies, pricing improvements, stronger governance, operational restructuring, cross-selling opportunities, or better strategic positioning. McKinsey’s 2026 work on M&A value creation highlights cost, capital, and revenue synergies as central levers, while also warning that synergy assumptions need to be credible, actionable, and tied to delivery discipline.

This matters because “growth potential” on its own is too vague. A stronger investment case identifies the operational levers that are expected to change performance in measurable terms.

3. Has due diligence gone beyond financials?

Financial diligence matters, but it is only one part of a serious M&A review. Ernest Young’s due diligence framework highlights financial, tax, commercial, operational, HR, IT, and cyber diligence as part of understanding value drivers, improving deal structures, and mitigating risk. That is an important point for investors. A business can look acceptable on headline numbers while still carrying operational weaknesses, technology risk, integration pressure, customer concentration, or people-related issues that materially affect value creation.

In most cases, investors should expect diligence to test not only the numbers, but also the assumptions behind the numbers.

4. How credible is the management and governance framework?

Global M&A investing depends heavily on people. Even a good asset can underperform if leadership is weak, incentives are poorly aligned, or governance is inconsistent after closing. That is why investors should look carefully at sponsor quality, operating capability, board oversight, reporting standards, and who is accountable for delivering the post-deal plan. BCG’s latest M&A research argues that repeatable capability and disciplined risk management materially improve the chances of value creation. McKinsey’s integration research also highlights the importance of leadership, cultural management, and retaining the right people if value is to be realised.

A good deal model with weak governance is still a weak investment case.

5. How realistic is the integration or execution plan?

One of the most common mistakes in M&A is treating execution as something that happens after the hard work is done.

PwC’s value creation report is useful here because it argues that value creation planning should be a blueprint, not a checklist, and that integration, diligence, operating model, technology plans, and synergy delivery all need to be thought about properly from the outset. McKinsey’s work on M&A trends and integration also reinforces that execution quality shapes whether strategic intent turns into outcomes.

For investors, the practical question is simple: is there a credible plan for what happens after the acquisition closes, and does that plan match the complexity of the asset?

6. Where does downside risk actually sit?

Not every risk in global M&A sits in the same place. Sometimes the pressure sits in leverage. Sometimes it sits in integration complexity, customer retention, regulatory approvals, key-person dependence, or unrealistic synergy assumptions. BCG’s 2026 research is particularly useful here because it identifies acquirer readiness and deal complexity as two of the most consistent drivers of severe downside. EY’s diligence framework also shows how off-balance-sheet exposures, accounting issues, legal risks, and functional weaknesses can materially affect outcomes.

Sophisticated investors usually want to know not only what can go right, but what could go wrong first, where that risk sits, and how the structure is meant to absorb it.

7. What does the capital structure look like?

Structure matters in all private investments, and global M&A is no exception. Investors should understand how the investment is financed, where their position sits in the structure, what protections exist, and how returns are expected to be generated and distributed. WIUS’ global M&A guide page frames its offering around structured financing rather than speculation, alongside quarterly, yearly, or end-of-term income options and founder co-investment alignment. That is relevant because serious investors usually want clarity on how cash flows, term, protections, and alignment work in practice before making an allocation.

The more opaque the structure, the more careful the investor should be.

8. How dependent is the outcome on macro timing?

One reason some investors are drawn to M&A is that value creation can be driven more by execution than by daily market sentiment. That said, no private market strategy operates in complete isolation from broader conditions.

PwC’s 2026 outlook notes that global M&A remains shaped by large-capital concentration, AI investment themes, and a market that is structurally reshaping rather than simply rebounding. McKinsey similarly points to a rapidly rebounding market in which certain sectors and buyer types are driving much of the value.

That means investors should assess how much of the thesis depends on macro conditions becoming more favourable, and how much depends on factors that can be controlled through execution, governance, and deal discipline.

9. Is there genuine alignment between investor and sponsor?

Alignment is one of the most important filters in private markets.

WIUS states on its global M&A page that every project it offers is one it has invested in itself, and that investors participate alongside the founders in institutional-grade acquisition projects. That type of alignment matters because it helps investors assess whether the sponsor is exposed to the same economics, risks, and incentives as the investor base.

Alignment does not remove risk, but it does change the quality of the conversation. It usually signals that the sponsor expects to succeed under the same structure it is presenting to others.

10. Does this allocation fit your wider portfolio?

This is often the most overlooked point. An M&A investment may be well structured and still be wrong for a particular investor. Sophisticated investors usually assess illiquidity, concentration, time horizon, correlation, cash flow needs, and role within the broader portfolio before allocating. That is especially important in private markets, where exit flexibility is lower and the investment case needs to be strong enough to justify long-term commitment.

In most cases, good private market outcomes begin before capital is deployed. They begin with clarity about purpose. If the role of the allocation is unclear, that should be resolved before the investment decision is made.